Fundraising Fox
/Companies
Sign in

Cambiotics

6 known investors

Find your way into Cambiotics

Sign up to see every warm intro you have to Cambiotics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cambiotics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Cambiotics develops a precision-formulated probiotic whose bacterial strains interact with PFAS ("forever chemicals") in the gut to support their removal from the body through the digestive system. Based on University of Cambridge research, it targets consumers exposed to PFAS, including first responders such as firefighters and military personnel, with a US product launch planned for 2026.

BiotechDeep TechWellness & Fitness

Founders & leadership

AL
Anna LindellVP of Technology & Co-founder
KR
Kiran Raosaheb PatilCo-founder
PH
Peter Holme JensenCo-founder

Investors · 6

True.reportedLondon · $190M

How we know: femtechinsider.com · Not right? Tell us

Also in the syndicate · 4

BioInnovation InstituteDKEIFO (Danish Export and Investment Fund)EIFO (the Danish Export and Investment Fund)

Funding

SEC filings, press & company announcements
  • Undisclosed amountseed fundingMar 2026 · 2 sources

    Collaborative Fund (lead), BioInnovation Institute, DK, EIFO (Danish Export and Investment Fund), EIFO (the Danish Export and Investment Fund), True

    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Danish Startup Raises $5M To Remove Forever Chemicals From Your Bodyathletechnews.com · Mar 2026Cambiotics Raises €4M for Probiotic Supplement to Remove PFAS from the Bodyfemtechinsider.com · Mar 2026

Frequently asked questions

What does Cambiotics do?
Cambiotics develops a precision-formulated probiotic whose bacterial strains interact with PFAS ("forever chemicals") in the gut to support their removal from the body through the digestive system. Based on University of Cambridge research, it targets consumers exposed to PFAS, including first responders such as firefighters and military personnel, with a US product launch planned for 2026.
Who are Cambiotics's investors?
Cambiotics's investors include Collaborative Fund, True..